| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | NEUTRAL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 5.81▼ | 5.78▼ | 5.78▼ | 6.09▼ | N/A |
| MA10 | 5.87▼ | 5.89▼ | 5.89▼ | 5.84▼ | N/A |
| MA20 | 6.06▼ | 6.15▼ | 6.19▼ | N/A | N/A |
| MA50 | 6.08▼ | 6.03▼ | N/A | N/A | N/A |
| MA100 | N/A | N/A | N/A | N/A | N/A |
| MA200 | N/A | N/A | N/A | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | N/A | N/A | N/A | N/A | N/A |
| RSI | N/A | N/A | N/A | N/A | N/A |
| STOCH | 27.106 | 32.545 | 31.203 | N/A | N/A |
| WILL %R | -80.583▼ | -73.196 | -79.528▼ | -71.321 | N/A |
| CCI | -81.325 | -83.229 | -81.231 | -37.526 | N/A |
|
Friday, February 21, 2020 03:55 PM
The collaborative effort is a who's who of the healthcare industry, with participation from AmerisourceBergen (NYSE:ABC), Amgen (NASDAQ:AMGN), Eli Lily (NYSE:LLY), Gilead Sciences (NASDAQ:GILD), ...
|
|
Friday, February 21, 2020 06:56 AM
Though he claimed the Boston company’s drug cured his own paralysis, evidence presented at trial showed he was never paralyzed. —Hector Armando Kellum, a former executive at Novartis (NYSE: NVS) ...
|
|
Friday, February 21, 2020 06:16 AM
The COPD Drugs Market Perspective, Comprehensive Analysis along with Major Segments and Forecast, 2020-2025. The COPD Drugs Market report is a valuable source of insightful data for business ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 21/02/20 | 5.94 | 6.01 | 5.75 | 5.76 | 33,600 |
| 20/02/20 | 5.98 | 6.24 | 5.61 | 6.00 | 123,300 |
| 19/02/20 | 6.00 | 6.12 | 5.76 | 5.87 | 43,800 |
| 18/02/20 | 6.66 | 6.66 | 5.50 | 6.09 | 117,300 |
| 14/02/20 | 6.16 | 6.83 | 6.00 | 6.75 | 156,200 |
| 13/02/20 | 5.88 | 7.35 | 5.42 | 6.20 | 672,100 |
| 12/02/20 | 5.17 | 6.00 | 5.17 | 5.65 | 112,000 |
| 11/02/20 | 5.25 | 5.45 | 5.00 | 5.22 | 95,100 |
| 10/02/20 | 5.58 | 5.78 | 5.25 | 5.25 | 74,500 |
| 07/02/20 | 6.15 | 6.15 | 5.57 | 5.59 | 104,400 |
|
|
||||
|
|
||||
|
|